Mark Chin - Insider Trading & Ownership

Entity
Individual
Location
20 Berkeley Square, Mayfair, London, United Kingdom
Summary
The estimated net worth of Mark Chin is at least $35.7 M dollars as of June 14, 2024. Mark Chin is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $35.5 M. Mark Chin is the Former Director of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $162 K. Mark Chin is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. (HARP) stock worth about $32.2 K. Mark Chin is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $25.6 K.
All Insider Reports
All Insider Reports

Ownership of Mark Chin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN Enliven Therapeutics, Inc. Director $35.5 M Jun 2, 2022
PYXS Pyxis Oncology, Inc. Former Director $162 K Apr 21, 2022
HARP Harpoon Therapeutics, Inc. Director $32.2 K Mar 8, 2024
ITRM Iterum Therapeutics plc Director $25.6 K Jun 15, 2023
IRON Disc Medicine, Inc. Director Jun 12, 2024

Insider Transactions Reported by Mark Chin:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership